Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brian Y. Ryu"'
Autor:
Jiyeon Park, Dongmoung Kim, Jin-Ok Lee, Hyeon-Chun Park, Brian Y. Ryu, Ju Han Kim, Sug Hyung Lee, Yeun-Jun Chung
Publikováno v:
Experimentalmolecular medicine. 54(3)
Despite growing evidence of the relevance of alternative splicing (AS) to cancer development and progression, the biological implications of AS for tumor behaviors, including papillary thyroid cancer (PTC), remain elusive. With the aim of further und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f16c9c563e8a727355c0a00b7d680b
https://pubmed.ncbi.nlm.nih.gov/35277656
https://pubmed.ncbi.nlm.nih.gov/35277656
Autor:
Hyung Joon Kim, Haemin Kim, Junho Chung, Zang Hee Lee, Bongjun Kim, Hong-Hee Kim, Sang Il Kim, Brian Y. Ryu
Publikováno v:
Bone Research, Vol 7, Iss 1, Pp 1-13 (2019)
Bone Research
Bone Research
Bone destruction induced by breast cancer metastasis causes severe complications, including death, in breast cancer patients. Communication between cancer cells and skeletal cells in metastatic bone microenvironments is a principal element that drive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13373ef71f5a5cd39f79db671f3fc7fd
http://link.springer.com/article/10.1038/s41413-019-0068-5
http://link.springer.com/article/10.1038/s41413-019-0068-5
Publikováno v:
Pharmacogenomics. 21(12)
Aim: Current gene-level prioritization methods aim to provide information for further prioritization of ‘disease-causing’ mutations. Since, they are inherently biased toward disease genes, methods specific to pharmacogenetic (PGx) genes are requi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3087ca92c88d168a0b3c6135ccec73a3
https://pubmed.ncbi.nlm.nih.gov/32700635
https://pubmed.ncbi.nlm.nih.gov/32700635
Autor:
Chan Hee Park, Soo Youn Lee, Ji Hye Park, Brian Y. Ryu, Junhee Yoon, Ju Han Kim, Su Youn Baik
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 9
International Journal of Molecular Sciences, Vol 21, Iss 3091, p 3091 (2020)
Volume 21
Issue 9
International Journal of Molecular Sciences, Vol 21, Iss 3091, p 3091 (2020)
Genetic variability can modulate individual drug responses. A significant portion of pharmacogenetic variants reside in the noncoding genome yet it is unclear if the noncoding variants directly influence protein function and expression or are present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31039089f4da4dae1b2cb193ca8b7337
http://europepmc.org/articles/PMC7247590
http://europepmc.org/articles/PMC7247590
Publikováno v:
Drug Safety. 40:65-80
Preemptive and multi-variant genotyping is suggested to improve the safety of patient drug therapy. The number of South Koreans who would benefit from this approach is unknown. We aimed to quantify the number of patients who may experience serious ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471491d5a5f70cb43548becccee751b6
https://doi.org/10.1007/s40264-016-0454-5
https://doi.org/10.1007/s40264-016-0454-5